Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
Volume 355, Issues 1–2, 17 August 1996, Pages 13-40
Research paperDNA adducts from chemotherapeutic agents
References (174)
- et al.
Relation between platinum-DNA adducts and complete remission in adult acute nonlymphocytic leukemia
Leukemia Res.
(1994) - et al.
DNA repair after mustard gas alkylation by sensitive and resistant Yoshida sarcoma cells in vitro
Chem.-Biol. Interactions
(1970) - et al.
Immunocytochemical analysis of in vivo DNA modification
Mutation Res.
(1990) - et al.
Increased sensitivity of u.v.-repair-deficient human cells to DNA-bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from micrococcus luteus
Mutation Res.
(1978) - et al.
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum adducts
Ann. Oncol.
(1991) DNA-binding products of nornitrogen mustard, a metabolite of cyclophosphamide
Chem.-Biol. Interactions
(1987)- et al.
32P-post-labelling of 7-methyl-dGMP, ring-opened 7-methyl-dGMP and platinated dGpG
Chem.-Biol. Interactions
(1990) - et al.
Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary
Gynecol. Oncol.
(1993) - et al.
Sequence preferences of DNA interstrand cross-linking agents: importance of minimal DNA structural reorganization in the cross-linking reactions of mechlorethamine, cisplatin, and mitomycin C
Tetrahedron
(1991) Preliminary characterization of the adducts formed between the antitumor compound cis-Pt(NH3)2Cl2 and DNA in vitro
Biochem. Biophys. Res. Commun.
(1982)
Escherichia coli mutants deficient in 3-methyladenine-DNA glycosylase
J. Mol. Biol.
(1980)
Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells
Exp. Cell Res.
(1994)
Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis
Mutation Res.
(1988)
The Walker 256 carcinoma: a cell type inherently sensitive only to those difunctional agents that can form DNA interstrand crosslinks
Mutation Res.
(1991)
Alkylated DNA: buoyant density changes and modes of decomposition
Biochim. Biophys. Acta
(1967)
Interstrand cross-linking of DNA by nitrogen mustard
J. Mol. Biol.
(1966)
Specific excision of methylation products from DNA of Escherichia coli treated with N-methyl-N″-nitro-N-nitrosoguanidine
Chem.-Biol. Interactions
(1970)
Reaction of alkylating mutagens and carcinogens with nucleic acids: detection and estimation of a small extent of methylation at O-6 of guanine in DNA by methyl methanesulfonate in vitro
Chem.-Biol. Interactions
(1972)
Methylation of DNA by 3H-14C-methyl-labelled N-methyl-N-nitrosourea: evidence for transfer of the intact methyl group
Chem.-Biol. Interactions
(1973)
Inactivation of bacteriophage T7 by mono- and di-functional sulphur mustards in relation to cross-linking and depurination of bacteriophage DNA
J. Mol. Biol.
(1969)
Repair of chemical carcinogen-induced damage in DNA of human lymphocytes and lymphoid cell lines. Studies on the kinetics of removal of O6-methylguanine and 3-methyladenine
Chem.-Biol. Interactions
(1986)
Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic action
Biochem. Pharmacol.
(1991)
Detection of sulfur mustard-induced DNA modifications
Chem.-Biol. Interactions
(1994)
Evidence for acrolein-modified DNA in peripheral blood leukocytes of cancer patients treated with cyclophosphamide
Mutation Res.
(1991)
Experimental and clinical studies on the treatment of cancer by dichloroethyl sulfide (mustard gas)
Ann. Surgery
(1931)
Synthese und Abbau cytostatisch wirksamer cyclischer N-Phosphamidester des
Angew. Chem.
(1958)
Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus Type III
J. Exp Med.
(1944)
Antibody-directed enzyme pro-drug therapy
Clin. Pharmacother.
(1994)
Estimation of interstrand DNA cross-linking resulting from mustard gas alkylation of HeLa cells
Chem.-Biol. Interactions
(1971/1972)
Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes
Cancer Res.
(1989)
Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines
Cancer Res.
(1988)
On the dimerisation in nucleic acids as a result of ultraviolet irradiation
J. Chem. Phys.
(1961)
Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalanines
J. Chem. Soc.
(1954)
Regulation of the formation of the major diethylstilbestrol-DNA adduct and some evidence of its structure
Carcinogenesis
(1994)
Genetic aspects of multidrug resistance
Cancer
(1992)
Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response
Cancer Res.
(1993)
Gene-specific damage and repair of DNA adducts and cross-links
Recognition between mitomycin C and specific DNA sequences for cross-link formation
Biochemistry
(1990)
Release of ultraviolet light-induced thymine dimers from DNA in E. coli K-12
On the activation of cyclophosphamide in vivo and in vitro
Arzneimittel-Forschung
(1963)
Studies on the mode of action of ibenzmethyzin
The reaction of mustar gas with nucleic acids in vitro and in vivo
Biochem. J.
(1960)
The reaction of mono- and di-functional alkylating agents with nucleic acids
Biochem. J.
(1961)
Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to DNA
Nature (Lond.)
(1964)
In vivo reactions of isotopically labelled alkylating agent
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II
Cancer Chemother. Pharmacol.
(1982)
Repair of DNA containing interstrand cross-links in Escherichia coli: sequential excision and recombination
Mechanism of the cytotoxic action of alkylating agents in mammalian cells and evidence for the removal of alkylated groups from deoxyribonucleic acid
Nature (Lond.)
(1966)
Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro
Environ. Health Perspect.
(1992)
Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962
Cancer Res.
(1965)
Cited by (247)
Recent advance of clinically approved small-molecule drugs for the treatment of myeloid leukemia
2023, European Journal of Medicinal ChemistryExperimental (FT-IR, UV-Vis) spectroscopic analysis and molecular docking investigations of anti-cancer drugs Alkeran and Bicalutamide
2022, Journal of Molecular StructureCitation Excerpt :Additionally, it may cause “DNA cross-linking from one guanine's N-7 position to another”, making it difficult to manufacture or transduce DNA from strand to strand. Finally, Alkeran is capable of inducing a broad variety of alterations in its action against cancer [49,50]. The establishment of hydrogen bonds inside a molecule has a significant impact on both the structure and characteristics of the molecule.
Glycyrrhetinic acid modified chlorambucil prodrug for hepatocellular carcinoma treatment based on DNA replication and tumor microenvironment
2022, Colloids and Surfaces B: BiointerfacesEffects of aniline on growth, oxidative and DNA damage of rice (Oryza sativa L.) seedlings
2022, Environmental Technology and InnovationJunctions in DNA: underexplored targets for therapeutic intervention
2022, Bioorganic and Medicinal ChemistryComprehensive quantum chemical calculations and molecular docking analysis of uracil mustard by first principle
2022, Journal of the Indian Chemical Society
- ∗
Haddow Laboratories, Institute of Cancer Research, Cotswold Road, Sutton, Surrey SM2 5NG, UK. Tel.: +44 181 643 8901. ext. 4660; Fax: +44 181 770 7290.
Copyright © 1996 Published by Elsevier B.V.